Approval · Notice of Compliance 27664 · 2022
NETVISION: Notice of Compliance 27664
Issued February 24, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27664
- Date
- February 24, 2022
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NETVISION | 02525542 | Dormant |
Medicinal ingredients
- GALLIUM 68 GA OXODOTREOTIDE 122 MBQ per ML